Estamos realizando la búsqueda. Por favor, espere...
1582
37
170
29108
4409
2600
347
389
Abstract: Subsequent to mass vaccination programs against COVID-19, diverse side effects have been described, both at the injection site, such as pain, redness and swelling, and systemic effects such as fatigue, headache, muscle or joint pain. On rare occasions, a lymphadenopathic syndrome may develop, raising the clinical suspicion of a lymphoproliferative disorder. We present the case of a 30-year-old woman who developed self-limiting left axillary lymphadenopathy following COVID-19 vaccination. To date, only seven similar cases with a complete clinicopathological description have been published, and fourteen cases have been notified to the European adverse events databases (Eudravigilance) in relationship with vaccination against COVID-19. It is important to be aware of this potential complication when a lymphadenopathic syndrome develops following vaccination, to avoid unnecessary treatment.
Fuente: Revista Española de Patologia, 2024, 57, 42-47
Editorial: Ediciones Doyma, S.L. Elsevier
Año de publicación: 2024
Nº de páginas: 6
Tipo de publicación: Artículo de Revista
DOI: 10.1016/j.patol.2023.01.002
ISSN: 1699-8855,1988-561X
Url de la publicación: https://doi.org/10.1016/j.patol.2023.01.002
Leer publicación
GERMAN MORENO DE JUAN
PÉREZ DEL BARRIO, AMAIA
HERRERA ROMERO, EDUARDO GERMÁN
MARIO GONZALEZ RUIZ
SANTIAGO MONTES MORENO
Volver